Cargando…
Targeting APP/AICD in Down syndrome
Autores principales: | Guidi, Sandra, Stagni, Fiorenza, Bartesaghi, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584133/ https://www.ncbi.nlm.nih.gov/pubmed/28881564 http://dx.doi.org/10.18632/oncotarget.18860 |
Ejemplares similares
-
Timing of therapies for Down syndrome: the sooner, the better
por: Stagni, Fiorenza, et al.
Publicado: (2015) -
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome
por: Giacomini, Andrea, et al.
Publicado: (2015) -
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome
por: Stagni, Fiorenza, et al.
Publicado: (2021) -
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives
por: Stagni, Fiorenza, et al.
Publicado: (2022) -
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome
por: Stagni, Fiorenza, et al.
Publicado: (2017)